Chiasmal herniation as a complication of bromocriptine therapy

Journal of Neuro-Ophthalmology

Volumn 16, Issue 4, 1996, Pages 252-257

  Taxel, Pamela ^a   Waitzman, David M ^a,b   Harrington, J Frederick ^a   Fagan, Robert H ^a   Rothfield, Naomi F ^a   Chen, Harry H ^a   Malchoff, Carl D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b Veterans Administration   (United States)

Author keywords

Bromocriptine; Macroprolactinoma; Optic chiasm; Prolactin; Visual field defect

Indexed keywords

EID: 85014078005     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/00041327-199612000-00005     Document Type: Article

References (15)

1. Molitch ME, Elton RL, Blackwell RE, et al. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multi-center study. J Clin Endocrinol Metab 1985; 60: 698-705.
2. Wass JAH, Williams J, Charlesworth M, et al. Bromocriptine in management of large pituitary tumors. Br Med J 1982; 284: 1908.
3. Bevan IS, Webster J, Burke CW, Scanlon MF. Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 1992; 13: 220-40.
4. Molitch ME. The pituitary. In: Melmed S, ed. Prolactinomas. Boston: Blackwell Scientific Publications, 1995: 443-77.
5. Fisher EG, DeGirolami U, Suojanen JN. Reversible visual deficit following debulking of a Rathke’s cleft cyst: a tethered chiasm? J Neurosurg 1994; 81: 459-62.
6. Scott RM, Sonntag VKH, Wilcox LM, Adelman LS, Rockel TH. Visual loss from optochiasmatic arachnoiditis after tuberculous meningitis. Case report. J Neurosurg 1977; 46: 524-6.
7. Decker RE, Carras R. Transsphenoidal chiasmapexy for correction of posthypophysectomy traction syndrome of optic chiasm. Case report. J Neurosurg 1977; 46: 527-9.
8. Cupps TR, Woolf PD. Primary empty sella syndrome with panhypopituitarism, diabetes insipidus, and visual field defects. Acta Endocrinologica 1978; 89: 445-60.
9. Lee F. Ischemic chiasma syndrome. Am J Neuroradiol 1983; 4: 777-80.
10. Vance ML, Ridgway EC, Thorner MO. Follicle-stimulating hormone- and alpha-subunit-secreting pituitary tumor treated with bromocriptine. J Clin Endocrinol Metab 1985; 61: 580-4.
11. Kaufman B, Tomsak RL, Kaufman BA, et al. Herniation of the suprasellar visual system and third ventricle into empty sellae: morphologic and clinical considerations. Am J Neuroradiol 1989; 10: 65-76.
12. Bevan JS, Adams CBT, Burke CW, et al. Factors in the outcome of transsphenoidal surgery for prolactinoma and non-functioning pituitary tumor including preoperative bromocriptine therapy. Clin Endocrinol 1982; 26: 541-56.
13. Esiri MM, Bevan JS, Burke CW, Adams CBT. Effect of bromocriptine treatment on fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland. J Clin Endocrinol Metab 1986; 63: 383-8.
14. Landolt AM, Osterwalder V. Perivascular fibrosis in prolactinomas: is it increased by bromocriptine? J Clin Endocrinol Metab 1984; 58: 1179-83.
15. Molitch ME. Pathologic hyperprolactinemia. Endocrinol Metab Clin North Am 1992; 21: 877-901.